Recall-by-Genotype (RbG) studies, which re-contact biobank participants based on specific genetic variants, offer unprecedented power for functional genomics and drug target validation but raise complex Ethical, Legal, and Social Implications...
This comprehensive guide details the FDA's requirements for adverse event (AE) and serious adverse event (SAE) reporting during clinical trials of drugs and biologics.
This article provides a comprehensive analysis of scientific misconduct in the biomedical field, targeting researchers, scientists, and drug development professionals.
This comprehensive guide empowers researchers, scientists, and drug development professionals to navigate the complex landscape of data security.
This comprehensive guide explores the European Code of Conduct for Research Integrity (ECCRI), detailing its core principles, practical application in biomedical research, strategies for navigating common challenges, and its role...
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on implementing the EthicsGuide six-step method for developing clinical practice guidelines (CPGs).
This comprehensive guide establishes essential ethical frameworks for managing laboratory data.
This article provides a complete guide for research institutions and pharmaceutical R&D teams to establish effective data integrity training programs.
This comprehensive guide examines the critical choice between Paper Lab Notebooks (PLNs) and Electronic Lab Notebooks (ELNs) in the context of data integrity—a cornerstone of scientific research, regulatory compliance, and...
This article provides a comprehensive analysis of research integrity training program effectiveness for biomedical researchers and drug development professionals.